- Kit/Kits
- 500/KITS
- Kit/Kits,
- 50000.00 - 50000.00 INR
- 35 INR INR
- FOR HUMAN USE
- Chemical Drug
- Tablets
- WHO recommends parenteral artesunate in preference to quinine for the treatment of severe P. Falciparum malaria in adults and children.
- Dry Place
Artisunate Kit is based on WHO recommended ACT-kit. Uncomplicated malaria is defined as symptomatic malaria without signs of severity or evidence of vital organ dysfunction. To counter the threat of resistance of P.falciparum to monotherapies, & to improve treatment outcome, combination of anti-malarials are now recommended by WHO for the treatment of falciparum malaria. NVBDCP recommends this combination as the ACT of choice for treating P.falciparum malaria all across India.
Composition:
Artisunate Kit:
Each blister pack contain 3 tablet of Artesunate 200mg and 1 tablet of sulphadoxine 750mg and Pyrimethamine 37.5mg
Indications:
Uncomplicated P. Falciparum Malaria
Pregnancy & Lactation:
Artisunate Kit is not to be given in 1st trimester of pregnancy. NVBDCP of India recommends Artesunate + Sulphadoxine plus Pyrimethamine ACT kit in 2nd & 3rd trimesters of pregnancy as per dosage given above.
Commercial Packing:
Single Kit containing 5 tablets
Storage Conditions: Store it at room temperature.
Key Feature:
- WHO-GMP Certified
- Packaging can be customize
- Hygienically packed
- Balanced composition
- Stability
- Highly effective
- 5,00,000 Per Month
- 30 DAYS
- All India
- WHO-GMP, ISO 9001:2015
Shop No.188, Vardhman Crown Mall, Plot No.2, Sector-19, Dwarka, New Delhi, Delhi, 110075, India
Phone :+918035918697